Bowel Screening Uptake Lower Among People in Their 50s, NHS Data Show

NHS England has highlighted a gap in bowel cancer screening participation, with new data showing that people in their 50s are less likely to return completed test kits. The figures, covering the period from April 2024 to March 2025, reveal that just over half of 54-year-olds took part in the programme.

Participation Rates by Age

The annual statistics indicate that 56.2% of 54-year-olds completed and returned their faecal immunochemical test (FIT) kits during the 12-month period. This rate is lower than the uptake observed in older age groups, according to the data released by NHS England.

Health officials have pointed to the importance of early detection, noting that screening can identify signs of bowel cancer before symptoms develop. The test, which is sent by post every two years to eligible individuals, looks for tiny traces of blood in stool samples.

National Screening Programme

Bowel cancer screening is offered to everyone aged 54 to 74 in England, with the programme gradually expanding to include people from age 50. The NHS has been progressively lowering the starting age, and invitations are now being sent to 50-year-olds in many areas.

The lower return rate among those in their 50s has prompted a renewed push from NHS England to encourage kit completion. The organisation has emphasised that the test is simple, private, and can be done at home.

Context of the Findings

Bowel cancer is one of the most common cancers in the UK, but survival rates improve significantly when the disease is caught at an early stage. Screening aims to detect cancer at a point when treatment is more likely to be effective, and can also find polyps that might become cancerous over time.

The NHS England data underscores a persistent challenge in public health messaging: reaching younger eligible cohorts who may not prioritise preventive screening. While uptake generally increases with age, the figures for people in their early 50s remain below the national target.

Further details on the screening programme and the full dataset are available via the NHS England website.